GEN Exclusives

More »

GEN Poll

Aug 01, 2013

GSK China Scandal

Chinese officials have detained 22 GlaxoSmithKline (GSK) employees and an unknown number of doctors in the last month, accusing them of misdeeds and bribery. The company is one of about 60 biopharmas currently under investigation by Beijing for pricing policies. (Learn more here.) Do you expect this scandal will have a lasting effect on China’s biopharma industry?

What long-term effect will the GSK scandal have on the biopharma industry in China?

No effect
Little effect
A big effect
Get out now, while you have the chance!

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »